Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$450K Sell
7,172
-1,157
-14% -$80.6K 0.13% 302
2025
Q4
$553K Buy
+8,329
New +$538K 0.18% 177

Other funds holding DXCM

AlphaGrep UK Ltd's DXCM Position: Q1 2026 in Review

AlphaGrep UK Ltd reduced its DexCom (DXCM) stake by 14% in Q1 2026, selling an estimated $80.6K and leaving 7,172 shares worth $450K. The position accounts for 0.13% of the portfolio, ranked #302.

AlphaGrep UK Ltd first reported a position in DXCM in Q4 2025 and has held it in 2 quarters since. The position peaked at $553K in Q4 2025. 960 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • AlphaGrep UK Ltd held 7,172 shares of DexCom worth $450K as of Q1 2026.
  • AlphaGrep UK Ltd sold 1,157 DexCom shares in Q1 2026, an estimated $80.6K.
  • DexCom made up 0.13% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #302 holding.
  • AlphaGrep UK Ltd first reported a position in DexCom in Q4 2025 and has held it in 2 quarters since.
  • AlphaGrep UK Ltd's DexCom position peaked at $553K in Q4 2025.
  • 960 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.